Product image of Eltrombopag Cipla (Eltrombopag) supplied by GNH India

Eltrombopag Cipla

Active Ingredient:
Eltrombopag
Origin:
EU

Eltrombopag Cipla (Eltrombopag)

Eltrombopag Cipla is a medication used to stimulate platelet production. This oral treatment is manufactured by Cipla Europe NV and is commonly prescribed for conditions affecting blood cell counts.

Manufacturer / TM Owner

Cipla Europe Nv

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Eltrombopag Cipla is primarily used to increase platelet levels in the blood. It is often prescribed for conditions that result in low platelet counts, such as certain types of anemia or other blood disorders. Patients may wonder, 'What is Eltrombopag used for?' and the answer is that it helps manage conditions where the body does not produce enough platelets on its own.

Side Effects

  • Common effects of Eltrombopag Cipla may include changes in liver function, which is why regular monitoring is important. Some users might experience mild gastrointestinal discomfort or headaches. It is essential to discuss any persistent or severe side effects with a healthcare provider.

Precautions & Warnings

  • Eltrombopag Cipla should be handled with care, especially for those with liver conditions. It is important to follow the prescribed dosage and schedule. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions.

Avoid Interactions

  • Eltrombopag Cipla may interact with certain medications, including those that affect liver enzymes. It is advisable to avoid alcohol while taking this medication, as it can exacerbate side effects. Always consult a healthcare provider before starting or stopping any medication.

Frequently Asked Questions

Eltrombopag Cipla is used to increase platelet production in conditions where the body does not produce enough platelets on its own.

Eltrombopag Cipla is taken orally, and the dosage should be determined by a healthcare provider based on individual needs.

Common side effects may include changes in liver function, gastrointestinal discomfort, and headaches.

Eltrombopag Cipla may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

The safety of Eltrombopag Cipla for long-term use should be discussed with a healthcare provider, who can monitor for any potential side effects.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Eltrombopag

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT